Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-20

FDA Approved: LEVETIRACETAM — Original Application (Method Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for a generic levetiracetam product from Method Pharmaceuticals, LLC, authorizing its market entry as a generic antiseizur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)